GREY:MPHMF - Post by User
Post by
YoloRoloon May 24, 2018 3:13pm
141 Views
Post# 28076984
OH NO COULD IT BE?!!?!?!?
OH NO COULD IT BE?!!?!?!?The Company has contracted with a confidential OTC pharmaceutical development and custom packaging company to help develop, contract manufacture and package the Company’s CannaMint Strips for worldwide distribution. The confidential OTC pharmaceutical company already has patented and patent-pending substrate technology for extended release oral films that will further enhance the Callitas patent-pending delivery.
Read more at https://www.stockhouse.com/news/press-releases/2018/05/24/callitas-health-enters-into-exclusive-development-and-intellectual-property#kHIgKd88qfPQPbAx.99
Ottawa/SASKATOON, Aug. 11, 2016 -CanniMed Ltd. has entered into a letter of intent with CTT Pharmaceutical Holdings Inc. (OTCQB:CTTH) to license CTT’s Orally Dissolvable Thin Film (ODF) Wafer technology. This industry-first collaboration will enable CanniMed Ltd. to develop and commercialize this novel, smoke-free, drug delivery system in both Canada and the United States.
https://www.cannimed.ca/blogs/news/cannabis-oral-thin-film-wafer
EDMONTON, May 1, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX:ACB) (OTCQB:ACBFF) (Frankfurt: 21P; WKN:A1C4WM) and CanniMed Therapeutics Inc. (TSX:CMED) ("CanniMed") today announced that Aurora has completed the acquisition of all issued and outstanding shares of CanniMed Therapeutics Inc. ("CanniMed") that it did not already own.
https://www.newswire.ca/news-releases/aurora-completes-cannimed-acquisition-681431641.html